To Compare the Effect of Receiving the Technology-based Training Along With the Conventional Therapy to the Conventional Therapy Alone on Executive Functions Among People With Traumatic Brain Injury With Mild to Moderate Cognitive Deficit
1 other identifier
interventional
60
1 country
1
Brief Summary
The goal of this clinical trial is to compare the effect of receiving the technology-based training along with the conventional therapy to the conventional therapy alone on executive functions among people with traumatic brain injury with mild to moderate cognitive deficit. It aims to answer:
- If there is significant improvement in executive function skills among people with traumatic brain injury receiving technology-based training along with conventional therapy when compared to people with traumatic brain injury receiving conventional therapy alone.
- To see if the demographic variable has any effect on the cognitive improvement Participants will in the intervention group will be given 45 minutes of extra training session using technology along with their usual rehabilitation session. And Participants in the control group will be receiving the usual rehabilitation sessions. Researchers will compare the changes in the outcome measures between the intervention and control group to see if the technology-based training along with conventional therapy had significant effect on executive skills among people with traumatic brain injury.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2022
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 25, 2022
CompletedFirst Submitted
Initial submission to the registry
September 27, 2023
CompletedFirst Posted
Study publicly available on registry
October 12, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2024
CompletedOctober 12, 2023
June 1, 2023
2.6 years
September 27, 2023
October 10, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Executive Function Performance Test (EFPT)
It's a performance-based assessment that measures the executive functions. It has score ranging from 0 to 50, where higher the score higher is the executive skills
2 times, one before the intervention and one after 6 weeks
Secondary Outcomes (2)
Cognitive functional independence measure scale (CogFIM)
2 times, one before the intervention and one after 6 weeks
Mini Mental State Examination -2 (MMSE-2)
2 times, one before the intervention and one after 6 weeks
Study Arms (2)
Intervention arm
EXPERIMENTALThe participants in the intervention arm will be receiving technology based training along with the conventional therapy
Control arm
ACTIVE COMPARATORThe participants in the control arm will be receiving the regular conventional therapy program
Interventions
Technology based intervention are training session given to the participants through devices which has software installed to train cognitive functions for patients with cognitive deficit.
Participants in the control group will receive only conventional therapy
Eligibility Criteria
You may qualify if:
- Subjects with traumatic brain injury i.e damage to the brain resulting from external mechanical force, such as rapid acceleration or deceleration, impact, blast waves, or penetration by a projectile
- Adults aged between 18 and 60 years old
- No previous history of head trauma
- With MMSE score \>10 and \< 23 (people with mild to moderate cognitive deficit)
- Ability to give consent and willingness to comply with cognitive rehabilitation program.
You may not qualify if:
- Pre-existing chronic illness that causes neurological symptoms or complications such as congenital disorder, history of stroke, tumor, brain infection or any other previous disorder due to brain damage affecting the cognition.
- History of any psychiatry disorders which affects the cognitive functions such as schizophrenia, bipolar disorder etc.
- Those who cannot follow basic simple instruction or comprehend simple commands
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Qatar Rehabilitation Institute, Hamad Medical Corporation
Doha, 3050, Qatar
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- No blinding was done hence its a open label study
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 27, 2023
First Posted
October 12, 2023
Study Start
May 25, 2022
Primary Completion
December 30, 2024
Study Completion
December 30, 2024
Last Updated
October 12, 2023
Record last verified: 2023-06
Data Sharing
- IPD Sharing
- Will not share
Patients' identity will not be revealed. The data will be coded and will be sent to other researchers for analysis purpose.